Mack David Henry 4
4 · PMV Pharmaceuticals, Inc. · Filed Jan 22, 2025
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-01-03−17,709→ 0 totalExercise: $0.53Exp: 2025-05-11→ Common Stock (17,709 underlying) - Exercise/Conversion
Common Stock
2024-12-03$0.53/sh+91,750$48,628→ 534,210 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-12-03−91,750→ 17,709 totalExercise: $0.53Exp: 2025-05-11→ Common Stock (91,750 underlying) - Exercise/Conversion
Common Stock
2025-01-03$0.53/sh+17,709$9,386→ 551,919 total
Holdings
- 147,915(indirect: See footnote)
Common Stock
- 165,307(indirect: See footnote)
Common Stock
- 56,978(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F2]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F3]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]The shares subject to the option are fully vested and immediately exercisable.